financetom
Business
financetom
/
Business
/
TransDigm Group Faces Limited Near-Term Upside, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TransDigm Group Faces Limited Near-Term Upside, RBC Says
Sep 8, 2025 8:33 AM

10:59 AM EDT, 09/08/2025 (MT Newswires) -- TransDigm Group's ( TDG ) limited near-term upside continues to weigh on investors' sentiments amid a continued period of uncertainty for its stock, RBC Capital Markets said in a Monday note.

Merger activity should be the greatest potential catalyst for the stock but the outlook for large M&A activity is limited to fiscal 2026, RBC analysts said.

The company's recent $5 billion debt offering to finance its special dividend is a "clear sign" that near-term larger M&A is unlikely, they added.

The commercial aftermarket for the aerospace market continues to show growth, but TransDigm's ( TDG ) recent underperformance is a cause for concern, the analysts said, adding that they think the company's potential to outperform peers is limited.

Expectations of declines in organic revenue and earnings before interest, taxes, depreciation, and amortization, along with a normalizing aftermarket, does not provide a "strong fundamental backdrop" for a material valuation re-rating, the analysts said.

The company's new CEO should continue to execute the company's playbook, but the stock is now transitioning from growth to capital allocation, "which would continue to limit a significant shift in sentiment," RBC said.

RBC downgraded the company's stock rating to sector-perform from outperform and reduced the price target to $1,385 from $1,550.

Price: 1264.17, Change: -6.88, Percent Change: -0.54

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved